Table 2.
Univariate and multivariate analysis of factors associated with overall survival.
Variables | N (deaths) | Median (95% CI) | P | Univariate HR (IC 95%) | P | Multivariate HR (95%CI) | P |
---|---|---|---|---|---|---|---|
Overall survival | 146 (100) | 12.6 (7.8-17.4) | |||||
Age (years) | |||||||
<60 | 70 (42) | 19.1 (13.8-24.5) | 0.066 | 1.4 (0.9-2.1) | 0.067 | ||
≧60 | 76 (58) | 10.0 (4.7-15.2) | |||||
Sex | |||||||
Female | 69 (41) | 20.7 (10.3-31.2) | 0.074 | 1.4 (0.9-2.1) | 0.076 | ||
Male | 77 (59) | 10.1 (3.07-17.1) | |||||
ECOG | |||||||
0-1 | 116 (77) | 16.7 (9.3-24.1) | 0.013 | 1.7(1.1-2.8) | 0.015 | 1.7 (1.2-2.5) | 0.004 |
>1 | 30 (23) | 6.7 (5.6-7.9) | |||||
Tobacco exposure | |||||||
Absent | 65 (43) | 12.6 (2.1-23.0) | 0.738 | 1.07 (0.7-1.5) | 0.739 | ||
Present | 81 (57) | 12.2 (6.4-18.0) | |||||
Wood-smoke exposure | |||||||
Absent | 92 (66) | 11.4 (6.5-16.4) | 0.832 | 0.9 (0.6-1.4) | 0.832 | ||
Present | 53 (34) | 15.9 (8.-23.7 | |||||
Asbestos exposure | |||||||
Absent | 133 (89) | 14.2 (1.9-74.3) | 0.454 | 1.5 (0.8-2.9) | 0.160 | ||
Present | 13 (11) | 55.6 (8.1 -103) | |||||
EFGR status | |||||||
EGFR-wild type | 50 (24) | 38.1 (1.9 -74.3) | 0.000 | 1.8 (1.4-2.3) | 0.000 | ||
EGFR-mutated | 22 (11) | 55.6 (8.1-103.1) | |||||
Unknown | 74 (65) | 6.2 (4.4-8.0) | |||||
Adenocarcinoma histology | |||||||
Negative | 18 (11) | 21.5 (9.9-33.0) | 0.232 | 0.6 (0.3-1.2) | 0.235 | ||
Positive | 128 (89) | 11.9 (6.8 - 17) | |||||
Albumin g/dl | |||||||
< 3.5 | 69 (53) | 6.9 (2.06-11.8) | 0.000 | 2.0 (1.4-3.0) | 0.001 | ||
3.5+ | 75 (46) | 21.5 (9.3-33.7) | |||||
Unknown | 2 (1) | 1.7 (NR) | |||||
Group | |||||||
Early palliative care | 73 (46) | 18.1 (7.9-28.4) | 0.029 | 1.6 (1.04-2.3) | 0.030 | 1.5 (1.03-2.3) | 0.034 |
Standard of care | 73 (54) | 10.5 (4.7-16.2) | |||||
Depression at baseline | |||||||
Absent | 69 (48) | 20.7 (14.5-27.0) | 0.000 | 1.0 (0.8-1.3) | 0.939 | ||
Present | 54 (47) | 6.0 (4.5-7.6) | |||||
Unknown | 23 (5) | NR | |||||
Anxiety at baseline | |||||||
Absent | 61 (45) | 15.1 (5.6-24.6) | 0.003 | 0.8 (0.7-1.2) | 0.329 | ||
Present | 62 (50) | 6.7 (4.7-8.7) | |||||
Unknown | 23 (5) | NR | |||||
QoL at baseline | |||||||
> 70 | 38 (23) | 27.0 (9.0-45.0) | 0.000 | 2.6 (1.7-4.1) | 0.000 | ||
≦ 70 | 99 (68) | 11.1 (6.5-15.8) | |||||
Unknown | 9 (9) | 3.4 (1.5-1.8) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; EGFR, epidermal growth factor receptor; QoL, quality of life.